Hot flushes and night sweats (HFNS) affect 65-85% of women after breast cancer treatment; they are distressing, causing sleep problems and decreased quality of life. Hormone replacement therapy is often either undesirable ...
Feb 14, 2012
0
0
Researchers from the University of Liverpool and the University of Edinburgh have found evidence that shows that people with cancer face a higher risk of mortality from COVID-19 compared with those without cancer.
Apr 15, 2024
0
119
A study published Online First by The Lancet Oncology, and linked to The Lancet Series on cancer in pregnancy, shows that children of women exposed to chemotherapy while pregnant develop as well as children in the general ...
Feb 9, 2012
0
0
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely ...
Jun 2, 2023
0
26
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Oct 8, 2012
0
0
Blocking the action of vascular endothelial growth factor (VEGF) with the new anti-VEGF drug aflibercept can curb the development of malignant ascites (excessive fluid in the abdomen), a common and painful complication of ...
Dec 20, 2011
0
0
Intra-uterine devices designed to prevent conception may also protect against cervical cancer, according to a study covering more than 20,000 women that was released on Tuesday.
Sep 13, 2011
1
0
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...
Oct 8, 2012
0
0
On the 25th anniversary of the Chernobyl nuclear disaster, a comment published by Lancet Oncology describes the known health consequences of the 1986 event. The authors are Kirsten B. Moysich, PhD, MS, and Philip McCarthy, ...
Apr 27, 2011
0
0
(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.
Mar 27, 2012
0
0
